The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Health & life sciences
Drugs & drug processes
Tick (check) box to add article to PDF "basket"
Microfluidic bioreactors allow chemical reactions to take place on a very small scale, saving time, money and materials. An EU-funded project has developed microfluidic bioreactor technologies that could lead to a wide range of applications, including innovative medicines.
Published: 24 August 2018
An EU-funded project developed a simple, affordable and effective vaccine strategy to prevent the incidence of both hepatitis C virus and HIV-1. This could significantly increase the life expectancy of people receiving antiretroviral therapy for HIV-1.
Published: 27 July 2018
Monoclonal antibodies have emerged as a powerful weapon in the fight against a variety of diseases, including several types of cancer - but producing them remains a costly process. Crystallisation is the way forward, say EU-funded researchers working on an innovation that could make it easier, greener and far more affordable.
Published: 6 July 2018
EU-funded researchers have analysed the efficacy and required dosage of several antibiotics licensed decades ago. Their findings could enable doctors to prescribe certain drugs with greater confidence and strengthen EU efforts to tackle the growing problem of drug resistance.
Published: 25 June 2018
An EU-funded project aims to identify and maximise the potential of novel vaccines to end the global tuberculosis epidemic. These could save lives, stem the spread of infection and shorten treatment for the often deadly, airborne disease.
Published: 21 June 2018
For patients with rare genetic mutations of the debilitating disease cystic fibrosis, there are few options for effective treatment. EU-funded researchers are working to meet their needs, using new developments in personalised medicine to advance the testing of novel and promising drugs.
Published: 19 June 2018
An EU- and industry-funded project has developed a mobile app enabling patients and healthcare professionals to more easily report suspected adverse drug reactions. It has also analysed social media to assess drug safety. Both initiatives have shown potential for strengthening the monitoring of medicines.
Published: 18 June 2018
Pre-eclampsia is a potentially life-threatening condition that can develop in pregnant women. A number of factors are known to increase the risk, but the actual causes of this hypertensive disorder remain unclear. Researchers in Kazakhstan were involved in an EU-funded project that discovered an exciting lead: the babys genes also appear to play a role.
Published: 11 June 2018
An EU- and industry-funded project has identified potential biomarkers that could indicate how likely a drug is to cause cancer at an earlier stage of testing than is currently possible, which could save drug companies time and money - and lead to safer drugs reaching patients faster.
Published: 8 June 2018
An international group of EU-funded researchers has investigated the safety and efficacy of using the drug deferiprone to treat children with the blood disorder beta-thalassaemia major. The news is good.
Published: 1 June 2018